Answers are grounded in this paper and cite their sources.
Preclinical study reveals that endoplasmic reticulum stress impairs insulin receptor signaling in obese mouse models, highlighting novel therapeutic targets for type 2 diabetes.
Obesity contributes to the development of type 2 diabetes, but the underlying mechanisms are poorly understood. Using cell culture and mouse models, we show that obesity causes endoplasmic reticulum (ER) stress. This stress in turn leads to suppression of insulin receptor signaling through hyperactivation of c-Jun N-terminal kinase (JNK) and subsequent serine phosphorylation of insulin receptor substrate-1 (IRS-1). Mice deficient in X-box-binding protein-1 (XBP-1), a transcription factor that modulates the ER stress response, develop insulin resistance. These findings demonstrate that ER stress is a central feature of peripheral insulin resistance and type 2 diabetes at the molecular, cellular, and organismal levels. Pharmacologic manipulation of this pathway may offer novel opportunities for treating these common diseases.
No takes yet. Share an insight, caveat, or question.
Özcan et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: